Head-to-head comparisons of medication uses, side effects, warnings, and more.
Lagevrio (molnupiravir) is an antiviral medication that was given Emergency Use Authorization (EUA) by the FDA in December 2021 to treat people with mild-to-moderate COVID-19. It's a capsule that's taken by mouth and a full course of treatment only lasts 5 days. Most people don't have many side effects with Lagevrio (molnupiravir). But possible side effects include diarrhea, nausea, and dizziness. Lastly, this medication doesn't have any known medication interactions.
Paxlovid (nirmatrelvir / ritonavir) is used to treat people with mild-to-moderate coronavirus SARS-CoV-2 (COVID-19) who are at high risk for severe illness. It's made up of two antiviral medications that you take by mouth. A full course of treatment only lasts 5 days. For the best results, you should start taking the medications as soon as possible, but within 5 days of having symptoms. The most common side effects from Paxlovid (nirmatrelvir / ritonavir) include changes in taste and diarrhea.
Update: As of May 2023, Paxlovid (nirmatrelvir / ritonavir) is fully FDA-approved to treat COVID-19 in adults. But it's still under emergency use authorization (EUA) for children ages 12-18 years old.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.